<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <!-- meta tags-->
	<meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
	<!--external style sheets-->
	<link href="../../style.css" type="text/css" rel="stylesheet" />

    <title>DCCPS: BRP: PCRB: Key Initiatives</title>
</head>

<body>
<div id="wrapper">
    <!-- NCI Banner -->
	<div id="head-row1">
		<img src="../../images/dccps-banner2.gif" alt="National Cancer Institute" width="1000" height="40" usemap="#Map" />
	</div>
	<!-- end of NCI Banner -->

<!-- DCCPS Banner / Search Field -->
  <div id="head-row2-brp">
	<div id="left2"><a href="../index.html"><img src="../../images/banner-brp.jpg" alt="Behavioral Research - Cancer Control and Population Sciences" width="730" height="70" /></a></div>
    
    <div id="brpright2">
	  <div id="brpnorth">
      <a href="http://twitter.com/NCICancerCtrl" title="Twitter">Twitter<img src="../../images/twitter-icon.png" title="Twitter" alt="Twitter" width="20" height="20" /></a><a href="../../exit_disclaimer.html"><img src="../../images/Icon_External_Link.png" width="12" height="12" alt="exit disclaimer" /></a>
      <a href="../../cr-communication-videos.html" title="Multimedia">Multimedia<img src="../../images/media-icon.gif" title="Multimedia" alt="Multimedia" width="20" height="20" /></a></div>
      <form method="get" action="http://search2.google.cit.nih.gov/search" name="search">
	    <input type="hidden" name="site" value="DCCPS" />
	    <input type="hidden" name="client" value="DCCPS_frontend" />
	    <input type="hidden" name="proxystylesheet" value="DCCPS_frontend" />
	    <input type="hidden" name="output" value="xml_no_dtd" />
	    <input type="hidden" name="filter" value="0" />
	    <input type="hidden" name="getfields" value="*" />
	    <label for="searchbox"><input id="searchbox" type="text" name="q" size="15" maxlength="255" class="htextf" value="Search" /></label>
	    <input type="image" src="../../images/hbutton.gif"  class="hbutton" name="btnG" id="btnG" alt="Search" />
	  </form><br class="clearfloat" />
    </div><br class="clearfloat" />
  </div>
  <!-- End of DCCPS Banner / Search Field -->
  <div id="navigation">
  <ul>
  	<li><a href="index.html">Home</a></li>
    <li><a href="about.html">About</a></li>
    <li><a href="key_initiatives.html" class="section-active">Key Initiatives</a></li>
    <li><a href="../funding.html">Funding</a></li>
    <li><a href="../resources.html">Resources</a></li>
    <li><a href="../research_tools.html">Tools</a></li>
  </ul>
    </div>
	
	<!-- Main Content -->
	<div id="mainarea">
    <!-- Left Column // DCCPS Link / Need Help Banner -->
	<div id="column-left1">
    <div id="dccps-link"><a href="../../index.html">Cancer Control &amp; Population Sciences Home</a></div>
	
    <div class="rounded-border">
	  <ul class="brpslist2">
		<li><a href="../index.html">Behavioral Research Program Home</a>
	  </ul>
	</div>
	
    <div class="rounded-border">
	  <ul class="brpslist3">
		<li><a href="index.html">Process of Care Research Branch</a>
	  </ul>
	</div>
    
	<p><a href="http://www.cancer.gov/help"><img src="../../images/help-tile.jpg" alt="Need Help? Contact us by phone (1-800-422-6237), Web, or e-mail" width="200" height="60" class="image1" /></a></p>
    </div>
    <!-- End of Left Column // DCCPS Link / Need Help Banner -->
    
    <!-- Right Column // Page Content -->
    <div id="column-mid2">
    <h1>Process of Care Research Branch (PCRB)</h1>
    <h2>Key Initiatives</h2>
    <div class="content">
    <h3>Priority Areas for Applied Cancer Screening Research: Strategic Planning Process</h3>
    
    <p><a name="fig1"></a><strong>Figure 1.  Numbered Point-Map Showing the 80 Statements </strong></p>
        
        <p><img src="images/fig1.jpg" alt="Figure 1:  Numbered Point-Map Showing the 80 Statements" width="375" height="272" border="0"></p>
        
        <p><a href="priorities_planning.html#fig1">Back</a></p>
        <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
        
        <hr />
        
        <p><a name="fig2"></a><strong>Figure 2.  Cluster-Point Map Showing 80 Statements and 10 Priority Areas</strong></p>
          <p><img src="images/fig2.jpg" alt="Figure 2:  Cluster-Point Map Showing 80 Statements and 10 Priority Areas" width="375" height="245" border="0"></p>
          <p><a href="priorities_planning.html#fig2">Back</a></p>
        <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
        
        <hr />
        
        <p><a name="fig3"></a><strong>Figure 3.  Cluster-Point Map Showing 80 Statements as Points within 10 Priority Areas and 4 Thematic Areas</strong></p>
        
        <p><img src="images/fig3.jpg" alt="Figure 3:  Cluster-Point Map Showing 80 Statements as Points within 10 Priority Areas and 4 Thematic Areas" width="375" height="245" border="0"></p>
        
        <p><a href="priorities_planning.html#fig3">Back</a></p>
        <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
        
        <hr />
        
        <p><a name="fig4"></a><strong>Figure 4.  Importance Ratings of the 10 Priority Areas</strong></p>
        
        <p><img src="images/fig4.jpg" alt="Figure 4:  Importance Ratings of Priority Areas" width="375" height="271" border="0"></p>
        
        <p><a href="priorities_planning.html#fig4">Back</a></p>
        <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
        
        <hr />
        
        <p><a name="fig5"></a><strong>Figure 5.  Feasibility Ratings of the 10 Priority Areas</strong></p>
        
        <p><img src="images/fig5.jpg" alt="Figure 5:  Feasibility Ratings of Priority Areas" width="375" height="250" border="0"></p>
        
        <p><a href="priorities_planning.html#fig5">Back</a></p>
        <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
        
        <hr />
        
        <p><a name="fig6"></a><strong>Figure 6.  Overall Pattern Match of the Correlation Between Importance and Feasibility by 10 Priority Areas</strong></p>
          <p><img src="images/fig6.jpg" alt="Figure 6:  Overall Pattern Match of the Correlation Between Importance and Feasibility by 10 Priority Areas" width="375" height="277" border="0"></p>
          <p><a href="priorities_planning.html#fig6">Back</a></p>
        <br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br /><br />
        
        <hr />
        
        <p><a name="fig7-16"></a><strong>Figure 7.  Statements Rated for Importance and Feasibility Shown by the Methodology Priority Area</strong></p>
        
        <table width="100%" border="0" cellspacing="0" cellpadding="5">
              <tr>
                <td align="center"><strong>Methodology</strong><br>
                    <img src="images/fig7.jpg" alt="Figure 7:  Statements Rated for Importance and Feasibility Shown by the Methodology Priority Area" width="300" height="263" border="0"></td>
                <td valign="top">Encourage innovative qualitative approaches to understanding barriers to screening. (1)<br>
                    <br>
                  Encourage more small-scale preliminary research projects. (3)<br>
                  <br>
                  Consider the difference between screening in the classic sense and case finding.   (17)<br>
                  <br>
                  Encourage replication studies with different populations so that they can be evaluated for best practices model. (22)<br>
                  <br>
                  Evaluate how to link national and state data on screening of cancer incidence and outcomes for those areas. (26)<br>
                  <br>
                  Consider quantifying the potential impact of directing efforts at particular populations via simulation modeling. (29)<br>
                  <br>
                  Support designs to test the aggregate, as well as the independent effects of multi-strategy interventions. (61)<br>
                  <br>
                  Model screening prevalence needed to reduce breast, cervix and colorectal cancer mortality by 2005 and 2010. (70)<br>
                  <br></td>
              </tr>
              <tr>
                <td align="right" valign="top"><img src="images/fig7b.jpg" alt="Figure 7:  Statements Rated for Importance and Feasibility Shown by the Methodology Priority Area" width="142" height="90" border="0"></td>
                <td valign="top">Encourage high quality reporting of published results, methods and outcomes, to create a coherent body of knowledge.   (72)<br>
                    <br>
                  Develop and test alternatives to the traditional experimental-control approach for evaluation of community-based studies. (77)<br>
                  <br>
                  Support application of current successful models of intention to treat designs for cancer screening. (82)<br>
                  <br>
                  Establish consensus on appropriate outcome measures for behavioral interventions. (85)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 8.  Statements Rated for Importance and Feasibility Shown by the Determinant Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Determinants</strong><br>
                    <img src="images/fig8.jpg" alt="Figure 8:  Statements Rated for Importance and Feasibility Shown by the Determinant Priority Area" width="300" height="264" border="0"></td>
                <td valign="top">Examine effects of screening with and without false positive results on worry/anxiety about cancer. (2)<br>
                    <br>
                  Understand ecological influences on cancer screening behavior. (4)<br>
                  <br>
                  Identify impact of false positive cancer screening tests on future screening behavior.  (27)<br>
                  <br>
                  Examine predictors of multiple screening behaviors simultaneously to determine how behaviors cluster. (32)<br>
                  <br>
                  Study community level predictors of cancer screening. (40)<br>
                  <br>
                  Explore the impact of social support on screening behaviors. (46)<br>
                  <br>
                  Support basic behavioral (pre-intervention, "fundamental") research on the role of culture and screening behavior.   (52)<br>
                  <br></td>
              </tr>
              <tr>
                <td valign="top" align="right"><img src="images/fig8b.jpg" alt="Figure 8:  Statements Rated for Importance and Feasibility Shown by the Determinant Priority Area" width="142" height="108" border="0"></td>
                <td valign="top">Support adoption of successful cancer screening intervention strategies for community based populations. (55)<br>
                    <br>
                  Test the specific impact of tailored interventions in increasing cancer screening behavior. (56)<br>
                  <br>
                  Identify "pathways" to early detection.   (62)<br>
                  <br>
                  Test strategies to improve follow-up of abnormal screening test results. (64)<br>
                  <br>
                  Study influences on the receipt of repeat cancer screening. (73)<br>
                  <br>
                  Understand the role of fear as a barrier to screening, and develop strategies to help people overcome it. (74)</td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 9.  Statements Rated for Importance and Feasibility Shown by the Theory Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Theory</strong><br>
                    <img src="images/fig9.jpg" alt="Figure 9: Statements Rated for Importance and Feasibility Shown by the Theory Priority Area" width="300" height="251" border="0"><br>
                    <br>
                    <img src="images/fig9b.jpg" alt="Figure 9: Statements Rated for Importance and Feasibility Shown by the Theory Priority Area" width="138" height="109" border="0" align="right"></td>
                <td>Encourage integration of different theoretical perspectives into intervention development.  (6)<br>
                    <br>
                  Research the relative effectiveness of different theories in increasing prevention/screening activities. (12)<br>
                  <br>
                  Encourage development of theory relating macro levels of influence to individual screening behavior. (57)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 10.  Statements Rated for Importance and Feasibility Shown by the Health Services Research Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Health Services</strong><br>
                    <img src="images/fig10.jpg" alt="Figure 10:  Statements Rated for Importance and Feasibility Shown by the Health Services Research Priority Area" width="325" height="274" border="0"><br>
                    <br>
                    <img src="images/fig10b.jpg" alt="Figure 10:  Statements Rated for Importance and Feasibility Shown by the Health Services Research Priority Area " width="137" height="93" border="0" align="right"></td>
                <td>Consider interventions addressing multiple behavioral concerns, not just screening. (14)<br>
                    <br>
                  Assess the relative value of factors that enable provider and patient screening behaviors in practice settings (particularly multiple screens). (30)<br>
                  <br>
                  Focus research on the translation of proven screening programs into actual clinical practice. (35)<br>
                  <br>
                  Determine how to integrate cancer preventive service delivery in the midst of the competing opportunities of the primary care setting. (45)<br>
                  <br>
                  Describe PSA screening practices among physicians. (48)<br>
                  <br>
                  Develop capacity building strategies for endoscopic colorectal cancer screening.  (53)<br>
                  <br>
                  Identify practices most able to adopt innovations in cancer prevention. (58)<br>
                  <br>
                  Describe the actual practices in HMOs to promote screening. (59)<br>
                  <br>
                  Examine information systems that facilitate transfer of screening guidelines to clinicians. (69)<br>
                  <br>
                  Assess the impact of different managed care settings on screening practices. (84)<br>
                  <br>
                  Identify ways to package cancer screening with other preventive services. (88)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 11.  Statements Rated for Importance and Feasibility Shown by the Policy Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Policy</strong><br>
                    <img src="images/fig11.jpg" alt="Figure 11:  Statements Rated for Importance and Feasibility Shown by the Policy Priority Area" width="325" height="252" border="0"><br>
                    <br>
                    <img src="images/fig11b.jpg" alt="Figure 11:  Statements Rated for Importance and Feasibility Shown by the Policy Priority Area " width="151" height="96" border="0" align="right"></td>
                <td>Assess the impact of the Breast and Cervical Cancer Prevention and Treatment Act of 2000. (68)<br>
                    <br>
                  Assess policy relevant to diagnostic and treatment service provisions in population screening programs. (87)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 12.  Statements Rated for Importance and Feasibility Shown by the Disparities Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Disparities</strong><br>
                    <img src="images/fig12.jpg" alt="Figure 12:  Statements Rated for Importance and Feasibility Shown by the Disparities Priority Area" width="325" height="257" border="0"><br>
                    <br>
                    <img src="images/fig12b.jpg" alt="Figure 12:  Statements Rated for Importance and Feasibility Shown by the Disparities Priority Area" width="133" height="101" border="0" align="right"></td>
                <td>Develop outreach strategies that respond to underserved populations in rural areas. (11)<br>
                    <br>
                  Increase research on the most effective educational approaches for low-literacy individuals. (15)<br>
                  <br>
                  Explore beyond race/ethnicity on the major cultural constructs that may be associated with screening. (23)<br>
                  <br>
                  Explore the extent to which "trust" is an issue with various ethnic populations.  (25)<br>
                  <br>
                  Support interventions for minority groups that focus on the relation of HPV and cervical cancer. (33)<br>
                  <br>
                  Develop and test strategies for reaching the hard core screening non-participant. (37)<br>
                  <br>
                  Test interventions to eliminate socioeconomic disparities in 
                  cancer screening. (41)<br>
                              <br>
                  Reduce disparities with respect to initial access to screening and abnormal follow-up in key cancer areas. (51)<br>
                  <br>
                  Test the feasibility of using new media technologies to educate underserved/poor regarding cancer screening. (60)<br>
                  <br>
                  Investigate similarities/differences in barriers to obtaining various cancer screening tests in different populations. (65)<br>
                  <br>
                  Encourage research on the cultural appropriateness of behavioral theories used to explain screening and inform interventions. (76)<br>
                  <br>
                  Study the importance of context especially among the hard to reach subpopulations and those who never screen. (80)<br>
                  <br>
                  Collect up to date data on cancer screening access among rural residents. (83)<br>
                  <br>
                  Diversify intervention research geographically. (86)<br>
                  <br>
                  Examine the feasibility of "low tech" screening for developing countries and underserved areas of the US.  (89)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 13.  Statements Rated for Importance and Feasibility Shown by the Decision Making Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Decision Making</strong><br>
                    <img src="images/fig13.jpg" alt="Figure 13:  Statements Rated for Importance and Feasibility Shown by the decision making Priority Area" width="325" height="256" border="0"><br>
                    <br>
                    <img src="images/fig13b.jpg" alt="Figure 13:  Statements Rated for Importance and Feasibility Shown by the decision making Priority Area" width="141" height="91" border="0" align="right"></td>
                <td>Support provider studies of decision making about colorectal cancer screening options. (5)<br>
                    <br>
                  Develop and test strategies to promote shared decision making to increase cancer screening. (16)<br>
                  <br>
                  Encourage research on decision making strategies in high risk families. (18)<br>
                  <br>
                  Develop a team model approach for prostate cancer patients to facilitate treatment decisions over short and long run. (19)<br>
                  <br>
                  Examine the issue of informed consent for screening. (34)<br>
                  <br>
                  Examine patient decision making and preferences for different colorectal cancer screening tests. (36)<br>
                  <br>
                  Assess patient and provider decision making when screening recommendations are uncertain (e.g., PSA testing). (39)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 14.  Statements Rated for Importance and Feasibility Shown by the Communication Priority Area</strong> </td>
              </tr>
              <tr>
                <td align="center"><strong>Communication</strong><br>
                    <img src="images/fig14.jpg" alt="Figure 14:  Statements Rated for Importance and Feasibility Shown by the Communication Priority Area" width="325" height="258" border="0"><br>
                    <br>
                    <img src="images/fig14b.jpg" alt="Figure 14:  Statements Rated for Importance and Feasibility Shown by the Communication Priority Area" width="143" height="104" border="0" align="right"></td>
                <td>Develop and test cancer risk communication messages across different ethnic/minority and cultural groups. (7)<br>
                    <br>
                  Develop and test gender specific messages for colorectal cancer screening. (8)<br>
                  <br>
                  Test strategies for increasing patient-provider communication regarding screening. (31)<br>
                  <br>
                  Develop a balanced prostate cancer screening message and determine effective ways to disseminate it. (43)<br>
                  <br>
                  Evaluate and test colorectal risk communications via multi-media methods. (54)<br>
                  <br>
                  Support educational interventions regarding the role of HPV in cervical cancer. (79)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 15.  Statements Rated for Importance and Feasibility Shown by the Risk/Genetic Assessment Priority Area</strong> </td>
              </tr>
              <tr>
                <td align="center"><strong>Risk/Genetic Assessment</strong><br>
                    <img src="images/fig15.jpg" alt="Figure 15:  Statements Rated for Importance and Feasibility Shown by the Risk/Genetic Assessment Priority Area" width="325" height="267" border="0"><br>
                    <br>
                    <img src="images/fig15b.jpg" alt="Figure 15:  Statements Rated for Importance and Feasibility Shown by the Risk/Genetic Assessment Priority Area" width="140" height="94" border="0" align="right"></td>
                <td>Anticipate the behavioral research issues likely to develop with the introduction of biomarker screening. (9)<br>
                    <br>
                  Study how people interpret genetic risk information, especially absolute versus relative risk. (10)<br>
                  <br>
                  Examine the policy issues related to genetic screening for cancer. (38)<br>
                  <br>
                  Examine psychosocial and other screening issues in first-degree relatives of cancer survivors. (49)<br>
                  <br>
                  Evaluate and assess the  psychosocial and system effects of genetic testing for cancers among high and average risk people. (50)<br>
                  <br>
                  Expand behavioral research in the area of screening for genetic risk for cancer. (66)<br>
                  <br>
                  Determine how risk assessment should be incorporated into screening programs. (67)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><strong>Figure 16.  Statements Rated for Importance and Feasibility Shown by the Cost Effectiveness Priority Area</strong></td>
              </tr>
              <tr>
                <td align="center"><strong>Cost Effectiveness</strong><br>

                    <img src="images/fig16.jpg" alt="Figure 16:  Statements Rated for Importance and Feasibility Shown by the Cost Effectiveness Priority Area" width="325" height="266" border="0"><br>
                    <br>
                    <img src="images/fig16b.jpg" alt="Figure 16:  Statements Rated for Importance and Feasibility Shown by the Cost Effectiveness Priority Area " width="137" height="97" border="0" align="right"></td>
                <td>Conduct cost-utility studies for new colorectal cancer screening tests on the horizon (e.g. virtual colonoscopy). (20)<br>
                    <br>
                  Study cost effectiveness of screening interventions. (63)<br>
                  <br>
                  Evaluate the effectiveness and costs of packaging (all) screening in the primary care setting. (78)<br>
                  <br>
                  Examine cost effectiveness of various early detection formats.  (81)<br>
                  <br></td>
              </tr>
              <tr>
                <td colspan="2"><a href="priorities_planning.html#fig7-16">Back</a></td>
              </tr>
              <tr>
                <td colspan="2"><hr></td>
              </tr>
              <tr>
                <td valign="top" colspan="2"><a name="fig17"></a><strong>Figure 17.  Concept Map Showing Priority and Thematic Areas  of Research for the Applied Cancer Screening Research Branch </strong></td>
              </tr>
              <tr>
                <td colspan="2"><img src="images/fig17.jpg" alt="Figure 17:  Concept Map Showing Priority and Thematic Areas  of Research for the Applied Cancer Screening Research Branch" width="325" height="267" border="0"><br>
                    <br>
                  <a href="priorities_planning.html#fig17">Back</a></td>
              </tr>
            </table>
    </div>
    </div>
    <!-- End of Right Column // Page Content -->
    <br class="clearfloat" />
    </div>
    <!-- End of Main Content -->
    
    <!-- Last Updated -->
    <div class="update">Last Updated: January 5, 2012</div>
    <!-- End of Last Updated -->
    
    <!-- Footer -->
    <div id="brpfoot-row1">
	<ul class="flist2">
    <li><a href="/index.html">Site Home</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/contact">Contact Us</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/web/policies">Policies</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/web/policies/accessibility">Accessibility</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/viewing-files">Viewing Files</a></li>
    <li>|</li>
    <li><a href="http://www.cancer.gov/global/web/policies/foia">FOIA</a></li>
    <li>|</li>
	<li><a href="/help.html">Help</a></li>
    <li>|</li>
    <li><a href="/site-map.html">Site Map</a></li>
  </ul>
	<br />

	<ul class="flist2">
    <li><a href="http://www.hhs.gov/">U.S. Department of Health and Human Services</a></li>
    <li>|</li>
  <li><a href="http://www.nih.gov/">National Institutes of Health</a></li>
  <li>|</li>
  <li><a href="http://www.cancer.gov/">National Cancer Institute</a></li>
  <li>|</li>
  <li><a href="http://www.usa.gov/">USA.gov</a></li>
  </ul>
  <div class="nih-tagline">NIHâ€¦Turning Discovery Into Health<sup>&#174;</sup></div>
	</div>
    <!-- End of Footer -->
</div>

<!-- Image map for head-row1 -->
<map name="Map" id="Map">
	<area shape="rect" coords="12,3,294,38" href="http://www.cancer.gov/" alt="National Cancer Institute" />
	<area shape="rect" coords="715,10,892,33" href="http://www.nih.gov" alt="U.S. National Institutes of Health" />
	<area shape="rect" coords="893,10,988,33" href="http://www.cancer.gov/" alt="National Cancer Institute" />
</map>
<!-- End of Image map for head-row1 -->

<!-- GA Code -->
<script type="text/javascript">

  var _gaq = _gaq || [];
  _gaq.push(['_setAccount', 'UA-25589575-1']);
  _gaq.push(['_trackPageview']);

  (function() {
    var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
    ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);
  })();

</script>
<!-- End of GA Code -->
<script language="JavaScript" type="text/javascript" src="/JS/Omniture/WA_DCCPS_PageLoad.js"></script>
</body>
</html>